Sensitivity of Medicare Claims to Identify Cancer Recurrence in Elderly Colorectal and Breast Cancer Patients
- 1 August 2016
- journal article
- applied methods
- Published by Wolters Kluwer Health in Medical Care
- Vol. 54 (8) , e47-e54
Abstract
Background: Researchers are increasingly interested in using observational data to evaluate cancer outcomes following treatment, including cancer recurrence and disease-free survival. Because population-based cancer registries do not collect recurrence data, recurrence is often imputed from health claims, primarily by identifying later cancer treatments after initial treatment. The validity of this approach has not been established. Research Design: We used the linked Surveillance, Epidemiology, and End Results-Medicare data to assess the sensitivity of Medicare claims for cancer recurrence in patients very likely to have had a recurrence. We selected newly diagnosed stage II/III colorectal (n=6910) and female breast cancer (n=3826) patients during 1994–2003 who received initial cancer surgery, had a treatment break, and then died from cancer in 1994–2008. We reviewed all claims from the treatment break until death for indicators of recurrence. We focused on additional cancer treatment (surgery, chemotherapy, radiation therapy) as the primary indicator, and used multivariate logistic regression analysis to evaluate patient factors associated with additional treatment. We also assessed metastasis diagnoses and end-of-life care as recurrence indicators. Results: Additional treatment was the first indicator of recurrence for 38.8% of colorectal patients and 35.2% of breast cancer patients. Patients aged 70 and older were less likely to have additional treatment (P < 0.05), in adjusted analyses. Over 20% of patients either had no recurrence indicator before death or had end-of-life care as their first indicator. Conclusions: Identifying recurrence through additional cancer treatment in Medicare claims will miss a large percentage of patients with recurrences; particularly those who are older.Keywords
This publication has 22 references indexed in Scilit:
- Identification of metastatic cancer in claims dataPharmacoepidemiology and Drug Safety, 2012
- Surveillance of Pancreatic Cancer Patients after Surgical ResectionAnnals of Surgical Oncology, 2011
- Epidemiology, survival, and costs of localized gastrointestinal stromal tumorsInternational Journal of General Medicine, 2011
- Impact of surveillance on survival after laryngeal cancer in the medicare populationThe Laryngoscope, 2009
- Death certificates provide an adequate source of cause of death information when evaluating lung cancer mortality: An example from the Mayo Lung ProjectLung Cancer, 2009
- Provider Case Volume and Outcomes Following Prostate BrachytherapyJournal of Urology, 2009
- Ten-Year Survival and Cost Following Breast Cancer Recurrence: Estimates from SEER-Medicare DataValue in Health, 2008
- Racial Differences in Clinical Progression Among Medicare Recipients After Treatment for Localized Prostate Cancer (United States)Cancer Causes & Control, 2006
- Studying Radiation Therapy Using SEER-Medicare-Linked DataMedical Care, 2002
- Determining Cause of Death in Prostate Cancer: Are Death Certificates Valid?JNCI: Journal of the National Cancer Institute, 2001